Using Drugs Known as CDK4/6 Inhibitors to Reduce Chance of Breast Cancer Recurrence — It’s Crucial to Understand Risks vs. Benefits

Using Drugs Known as CDK4/6 Inhibitors to Reduce Chance of Breast Cancer Recurrence — It’s Crucial to Understand Risks vs. Benefits

NOW
PLAYING
The Latest for CDK4/6 Inhibitors in Breast Cancer Treatment: Weighing the Risks vs. Benefits
NOW
PLAYING
For Advanced Breast Cancer With a PIK3CA Mutation, A New Three-Drug Combination Doubles Progression-Free Survival, According to New Study
NOW
PLAYING
Promising Targeted Therapy, Padcev, Falls Short of Meeting Goals for Advanced Breast Cancer - But May Still Have Future Treating Disease
NOW
PLAYING
New Pan-Tumor Approval For Targeted Drug Enhertu: Industry Leader Ashley Gaines Says Many More Oncologists & Patients Need To Be Aware of HER2 Testing
NOW
PLAYING
I Can’t Hide My Cancer Anymore Says Veteran News Anchor, 66, Showing Off New Hairstyle While Sharing Breast Cancer Returned After 16-Years Dormant
NOW
PLAYING
"Enjoy Your Life"-- Boston Mom, 51, Finds Hope With New Treatment For Aggressive Breast Cancer

Patient Pathfinder:

Clinical Trial Finder

Are you looking for other treatment options?
Right now there are ... breast cancer trials in the U.S. within 100 miles of

Enter your zip code and travel distance to explore trials in your area...

×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.

Please confirm you are a US based health care provider:

Yes, I am a health care Provider No, I am not a health care provider